Published in Eur J Epidemiol on January 01, 2001
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One (2010) 1.90
Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen. Interdiscip Perspect Infect Dis (2010) 1.04
Epidemiology and clinical manifestations of enteroaggregative Escherichia coli. Clin Microbiol Rev (2014) 1.01
An investigation of the diversity of strains of enteroaggregative Escherichia coli isolated from cases associated with a large multi-pathogen foodborne outbreak in the UK. PLoS One (2014) 0.93
Association of putative pathogenicity genes with adherence characteristics and fimbrial genotypes in typical enteroaggregative Escherichia coli from patients with and without diarrhoea in the United Kingdom. Eur J Clin Microbiol Infect Dis (2007) 0.93
Two novel EHEC/EAEC hybrid strains isolated from human infections. PLoS One (2014) 0.90
Serotypes, intimin subtypes, and antimicrobial resistance patterns of atypical enteropathogenic Escherichia coli isolated in England from 1993 to 1996. Eur J Clin Microbiol Infect Dis (2006) 0.87
Enteroaggregative coli: A Pathogen Bridging the North and South. Curr Trop Med Rep (2014) 0.78
Genotypic and phenotypic characterisation of enteroaggregative Escherichia coli from children in Rio de Janeiro, Brazil. PLoS One (2013) 0.77
Enteroaggregative Escherichia coli have evolved independently as distinct complexes within the E. coli population with varying ability to cause disease. PLoS One (2014) 0.77
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis (1989) 4.52
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen. J Infect Dis (1990) 4.43
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
Prevalence of Escherichia coli strains with localized, diffuse, and aggregative adherence to HeLa cells in infants with diarrhea and matched controls. J Clin Microbiol (1989) 3.02
Acute and chronic diarrhoea and abdominal colic associated with enteroaggregative Escherichia coli in young children living in western Europe. Lancet (1997) 2.58
Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. Infect Immun (1998) 2.49
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J Clin Invest (1991) 2.35
Laboratory investigation of enteroaggregative Escherichia coli O untypeable:H10 associated with a massive outbreak of gastrointestinal illness. J Clin Microbiol (1997) 2.08
HEp-2 adhesion and the expression of a 94 kDa outer-membrane protein by strains of Escherichia coli belonging to enteropathogenic serogroups. J Gen Microbiol (1988) 1.99
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa. Infect Immun (1992) 1.73
A study of infectious intestinal disease in England: plan and methods of data collection. Commun Dis Public Health (1999) 1.36
Phenotypic and genetic analysis of diarrhea-associated Escherichia coli isolated from children in the United Kingdom. J Pediatr Gastroenterol Nutr (2001) 1.13
Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: a case-control study. J Infect Dis (1998) 1.11
Enteroadherent Escherichia coli and diarrhea in children: a prospective case-control study. J Clin Microbiol (1996) 0.97
Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea. J Clin Microbiol (1993) 0.92
A pilot study of infectious intestinal disease in England. Epidemiol Infect (1995) 0.90
Enteroaggregative Escherichia coli: another cause of acute and chronic diarrhoea in England? J Pediatr Gastroenterol Nutr (1994) 0.89
Characterization of enteroaggregative Escherichia coli isolated from outbreaks of diarrhoeal disease in England. Epidemiol Infect (1999) 0.88
Detection of enteroadherent Escherichia coli associated with diarrhoea in Italy. J Med Microbiol (1994) 0.85
Improved detection of enteroaggregative Escherichia coli using formalin-fixed HEp-2 cells. Lett Appl Microbiol (1997) 0.82
Enteroaggregative Escherichia coli. J Appl Microbiol (1998) 0.82
Enteroaggregative strains of Escherichia coli belonging to serotypes O126:H27 and O44:H18 express antigenically similar 18 kDa outer membrane-associated proteins. FEMS Microbiol Lett (1995) 0.77
Antigenic cross-reactions between fimbriae expressed by Salmonella enteritidis, S. dublin and an 18 kDa outer membrane associated protein expressed by Escherichia coli O126:H27. FEMS Microbiol Lett (1994) 0.75
Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med (2001) 6.67
Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol (1993) 6.47
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East. J Hyg (Lond) (1977) 4.46
Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol (1993) 4.46
Risk factors for and prevention of sporadic infections with vero cytotoxin (shiga toxin) producing Escherichia coli O157. Lancet (1998) 4.45
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 4.18
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Chloramphenicol resistance in the typhoid bacillus. Br Med J (1972) 3.79
Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet (1999) 3.78
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet (1993) 3.72
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69
A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med (1998) 3.62
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol (1988) 3.25
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J Clin Microbiol (1977) 3.11
Molecular studies of an fi+ plasmid from strains of Salmonella typhimurium. Mol Gen Genet (1973) 3.05
Application of agarose gel electrophoresis to the characterization of plasmid DNA in drug-resistant enterobacteria. J Gen Microbiol (1979) 3.02
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Mutagenesis of plasmid DNA with hydroxylamine: isolation of mutants of multi-copy plasmids. Mol Gen Genet (1976) 2.92
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med (1998) 2.73
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47
Subdivision of Salmonella enteritidis PT 4 by pulsed-field gel electrophoresis: potential for epidemiological surveillance. FEMS Microbiol Lett (1994) 2.44
Outcome of pregnancy in a woman with an increased body mass index. BJOG (2005) 2.38
Screening for enteropathogenic Escherichia coli in infants with diarrhea by the fluorescent-actin staining test. Infect Immun (1991) 2.35
Views of junior doctors about their work: survey of qualifiers of 1993 and 1996 from United Kingdom medical schools. Med Educ (2000) 2.29
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Prevalence of faecal excretion of verocytotoxigenic Escherichia coli O157 in cattle in England and Wales. Vet Rec (2003) 2.22
Clinical predictors of admission in infants with acute bronchiolitis. Arch Dis Child (2011) 2.18
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16
Genetic and molecular characterisation of some non-transferring plasmids. Mol Gen Genet (1974) 2.16
The emergence of ciprofloxacin resistance in Salmonella typhimurium. J Antimicrob Chemother (1990) 2.13
The ecological validity of tests of executive function. J Int Neuropsychol Soc (1998) 2.12
Isolation of vero cytotoxin-producing Escherichia coli O157 from wild birds. J Appl Microbiol (1997) 2.08
Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03
The impact of maternal depression in pregnancy on early child development. BJOG (2008) 2.02
Cocaine-related vasculitis causing upper-limb peripheral vascular disease. Ann Intern Med (2000) 2.01
Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut (1993) 1.98
Structural and immunochemical homogeneity of Aeromonas salmonicida lipopolysaccharide. J Bacteriol (1984) 1.96
BD8 certification of visually impaired people. Br J Ophthalmol (1998) 1.96
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology (1996) 1.92
Retirement intentions of doctors who qualified in the United Kingdom in 1974: postal questionnaire survey. J Public Health Med (2001) 1.92
Beta-lactamase of R factors. J Bacteriol (1968) 1.89
Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. Mol Cell Probes (1991) 1.86
Interactions of group H resistance factors with the F factor. J Bacteriol (1973) 1.85
Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification. J Infect Dis (1990) 1.84
cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol (1991) 1.82
The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect (2001) 1.81
Haemorrhagic colitis in child after visit to farm visitor centre. Lancet (1995) 1.79
Incidence of K1 antigen in Escherichia coli isolated from blood and cerebrospinal fluid of patients in the United Kingdom. J Clin Pathol (1977) 1.79
Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect (1993) 1.78
Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics (2001) 1.78
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology (2003) 1.78
Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg Infect Dis (1997) 1.75
Molecular comparison of plasmids encoding heat-labile enterotoxin isolated from Escherichia coli strains of human origin. J Bacteriol (1980) 1.75
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74
Identification of enteropathogenic Escherichia coli isolated in Britain as enteroaggregative or as members of a subclass of attaching-and-effacing E. coli not hybridising with the EPEC adherence-factor probe. J Med Microbiol (1991) 1.73
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa. Infect Immun (1992) 1.73
Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage. Lancet (1983) 1.73
Mapping of a plasmid, coding for colonization, factor antigen I and heat-stable enterotoxin production, isolated from an enterotoxigenic strain of Escherichia coli. J Bacteriol (1982) 1.73
High-level resistance to ciprofloxacin in Escherichia coli. Lancet (1997) 1.72
Patients' choices and perceptions after an invitation to participate in treatment decisions. Soc Sci Med (1992) 1.72
Text entry on handheld computers by older users. Ergonomics (2000) 1.69
Principles for the management of penetrating cardiac wounds. Ann Surg (1979) 1.69
Fertility inhibition in strains of Salmonella typhimurium. Mol Gen Genet (1972) 1.69
An examination of verbal working memory capacity in children with specific language impairment. J Speech Lang Hear Res (1999) 1.69
Plasmids coding for colonization factor antigen I and heat-stable enterotoxin production isolated from enterotoxigenic Escherichia coli: comparison of their properties. Infect Immun (1981) 1.68
Genetic control and properties of coli surface antigens of colonization factor antigen IV (PCF8775) of enterotoxigenic Escherichia coli. Infect Immun (1988) 1.67
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK. Epidemiol Infect (1988) 1.66
Characterization of a putative colonization factor (PCFO166) of enterotoxigenic Escherichia coli of serogroup O166. J Gen Microbiol (1989) 1.65
Expression of CFA/I fimbriae is positively regulated. Microb Pathog (1990) 1.65
Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study. BJOG (2002) 1.64
Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun (2000) 1.64
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
Autoimmunity--a perspective. Annu Rev Immunol (1983) 1.62
Ultrastructural studies of early morphogenesis and cytodifferentiation in the embryonic mammalian pancreas. Dev Biol (1968) 1.62
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill (2011) 1.61
Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection. J Clin Microbiol (2003) 1.61
Antenatal domestic violence, maternal mental health and subsequent child behaviour: a cohort study. BJOG (2011) 1.60
Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis. Br Med J (1970) 1.59
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther (1999) 1.59
Infant morbidity in an Indian slum birth cohort. Arch Dis Child (2007) 1.58
Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci (2001) 1.57